{"ModuleTitle": "Company Description", "CompanyName": "Rigel Pharmaceuticals, Inc.", "Symbol": "RIGL", "Address": "1180 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, California, 94080, United States of America", "Phone": "", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to\r\ndiscovering, developing and providing novel small molecule drugs that\r\nsignificantly improve the lives of patients with immune and hematologic\r\ndisorders, cancer and rare diseases. Our pioneering research focuses on\r\nsignaling pathways that are critical to disease mechanisms. Our first U.S. Food\r\nand Drug Administration (FDA) approved product is TAVALISSE\u00ae (fostamatinib\r\ndisodium hexahydrate), the only oral spleen tyrosine kinase (SYK) inhibitor, for\r\nthe treatment of adult patients with chronic immune thrombocytopenia (ITP) who\r\nhave had an insufficient response to a previous treatment. The marketing\r\nauthorization application (MAA) for fostamatinib has been approved by the\r\nEuropean Commission (EC) in Europe for the treatment of chronic ITP in adult\r\npatients who are refractory to other treatments, and will be marketed in Europe\r\nunder the name TAVLESSE\u00ae (fostamatinib).&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f27%2f0001558370-20-001624.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Dean L. Schorno", "title": "Chief Financial Officer & Executive Vice President"}, {"name": "Raul R. Rodriguez", "title": "President, Chief Executive Officer & Director"}, {"name": "Wolfgang Dummer", "title": "Chief Medical Officer & Executive Vice President"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}